Your browser doesn't support javascript.
loading
Nuclear factor kappa B: a pivotal role in the systemic inflammatory response syndrome and new target for therapy.
Christman, J W; Lancaster, L H; Blackwell, T S.
Afiliación
  • Christman JW; Department of Medicine, Vanderbilt University School of Medicine and the Department of Veterans Affairs, Nashville, TN 37322-2650, USA. john.christman@mcmail.vanderbilt.edu
Intensive Care Med ; 24(11): 1131-8, 1998 Nov.
Article en En | MEDLINE | ID: mdl-9876974
NF-kappaB is an important transcription factor complex that appears to play a fundamental role in regulating acute inflammation through activation of the cytokine cascade and production of other pro-inflammatory mediators. There is increasing evidence that NF-kappaB is important in the pathobiology of disease states such as SIRS, MODS and ARDS; therefore, therapeutic interventions aimed at limiting NF-kappaB activation and down-regulating production of inflammatory mediators could prove to be beneficial in decreasing host-derived tissue injury and organ dysfunction. Specific interventions that hold promise for suppressing NF-kappaB activation include the use of antioxidants, inhibition of NIK and the IKK signalsome, treatment with proteasome inhibitors, induction of endotoxin tolerance and, possibly the use of corticosteroids in selected patients.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: FN-kappa B / Síndrome de Respuesta Inflamatoria Sistémica Límite: Humans Idioma: En Revista: Intensive Care Med Año: 1998 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: FN-kappa B / Síndrome de Respuesta Inflamatoria Sistémica Límite: Humans Idioma: En Revista: Intensive Care Med Año: 1998 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos